© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
[2017] VCAT 822
Victorian Civil and Administrative Tribunal
2017-06-09
Original judgment source is linked above.
Review and Regulation List - medical practitioner - inappropriate prescription and medical treatment - prescription of opioids and benzodiazepines - inappropriate treatment of persons with whom shared a close personal relationship - breach of S8 permit obligations - agreed facts and findings and joint proposed determinations - Medical Practice Act 1994 (Vic) s 3(1), Health Professions Registration Act 2005 (Vic) s 3(1), Health Practitioner Regulation National Law (Victoria) Act 2009 (Vic) s 5(a).
Medical Board of Australia v Griffiths (Review and Regulation) [2017] VCAT 822
With the agreement of the respondent the Tribunal finds as follows:
Inappropriate Prescribing and/or Medical Treatment
Inappropriate treatment of a person with whom shared a close personal or family relationship.
Prescribing a drug of dependence in circumstances where knew or ought to have known that the patient was a drug-dependent person
Breach of permit obligations; prescribing Schedule 8 poisons without a permit, after the expiry of the permit, in excess of maximum specified dosages
Note: Allegations 28 and 31 were withdrawn. References to allegations are to the Amended Notice of Allegations dated 11 November 2016.
Pursuant to section 196(2) of the Health Practitioner Regulation National Law (Victoria) Act 2009 (Vic), the Tribunal orders:
3.1 Dr Griffiths must undertake and successfully complete a program of education or one-to-one education, approved by the Medical Board of Australia (Board) that includes a reflective practice report in relation to pharmacotherapy and prescribing of medication in accordance with Drugs and Poisons Legislation and training in relation to the code of conduct for doctors in Australia, specifically working with patients and managing personal relations (the education).
3.2 Within one (1) month of the imposition of these conditions, Dr Griffiths must, on the approved form (HPN24), nominate for approval by the Board an education course or one-to-one education, assessment or program addressing the topics required. Dr Griffiths must ensure:
3.2.1 The nomination includes a copy of the curriculum of the education;
3.2.2 The education consists of a minimum of twenty-four (24) hours;
3.2.3 If nominating one-to one education, to nominate a person(s) to be approved by the Board to act as the educator and provide an acknowledgement that AHPRA will obtain a report from the approved educator at the conclusion of the education: and
3.2.4 If nominating one-to one education, that the nomination of an educator is accompanied by acknowledgment on the approved form (HPNA11), from the nominated educator and by an education plan outlining the form the education will take and how the topics will be addressed.
3.3 Dr Griffiths must complete the education within nine (9) months of the notice of the Board's approval of the education.
3.4 Within six (6) months of completing the education, Dr Griffiths is to provide to AHPRA:
- 3.4.1 Evidence of successful completion of the education; and
- 3.4.2 A report demonstrating, to the satisfaction of the Board, that Dr Griffiths has reflected on the issues that gave rise to this condition requiring he undertake education and how Dr Griffiths has incorporated the lessons learnt in the education into Dr Griffiths' practice.
3.5 At the completion of the education, Dr Griffiths must submit to three (3) audits of his practice (the audits), including any supporting records, by permitting an auditor approved by the Board (auditor) to attend any and all places of practice (public and private) for the purpose of the audit and by permitting the auditor to provide reports in relation to the findings of the audits. The audits and the audit reports are to focus on record keeping, Dr Griffiths' prescribing practices including his use of Schedule 4 and 8 poisons and whether Dr Griffiths is complying with Drugs and Poisons Legislation, and must include, at a minimum, an audit of Dr Griffiths' patient records.
3.6.1 The first audit must take place within three (3) months of Dr Griffiths' return to practice;
3.6.2The second audit must take place within six (6) months of the first audit; and
3.6.3 The third audit must take place within twelve (12) months of the second audit.
3.7 Within one (1) month of the imposition of these conditions, Dr Griffiths must:
3.7.1 Make contact with a Board approved auditor and establish an audit plan outlining the form the audits will take and how the areas of concern for the Board will be addressed. The audits will take the form determined by the auditor;
3.7.2 Provide the Board approved auditor with a copy of the conditions on his registration;
3.7.3 Provide to AHPRA, on the approved form (HP8), acknowledgement that AHPRA will seek reports from the auditor; and
3.7.4 Provide to AHPRA a copy of the audit plan, together with written acknowledgement from the auditor on the approved form (HPNA8).
For the purposes of this condition, 'mentoring' is defined as a relationship in which a skilled registered practitioner (the mentor) helps to guide the professional development of another practitioner.
3.8 Dr Griffiths must undertake a twelve (12) month period of mentoring by another registered health practitioner in relation to pharmacotherapy and prescribing of medication in accordance with Drugs and Poisons Legislation; appropriate prescription of drugs of dependency; appropriate medical management and/or referral of drug-dependent patients; compliance with the code of conduct for doctors in Australia, including working with patients and managing personal relations, and maintenance of the practitioner's own health and well-being.
3.8.1 The mentoring must comprise a minimum of twelve (12) monthly sessions occurring over a twelve (12) month period with each session being of at least one (1) hour duration.
3.8.2 Within one (1) month of the imposition of these conditions, Dr Griffiths must, on the approved form (HPN16) nominate a person(s) to be approved by the Board to act as mentor. Dr Griffiths must ensure that the nomination is accompanied by acknowledgement, on the approved form (HPNA16), from the nominated person(s).
3.8.3 Within one (1) month of the imposition of these conditions, Dr Griffiths must provide to AHPRA, on the approved form (HP16), acknowledgement that AHPRA may seek reports from the approved mentor on any or all of the following occasions:
- 3.8.3.1 every three (3) months;
- 3.8.3.2 at the conclusion of the mentoring relationship in order to confirm the outcomes of the mentoring;
- 3.8.3.3 whenever the mentor has a concern or becomes aware of a concern regard Dr Griffith's conduct or professional performance, and
- 3.8.3.4 when otherwise directed by AHPRA or the Board.
3.8.4 In the event an approved mentor is no longer willing or able to provide the mentoring required Dr Griffiths is to provide a new nomination in the same terms as previous nominations. Such nomination must be made by Dr Griffiths within twenty-one (21) days of becoming aware of the termination of the mentoring relationship.
3.8.5 Within six (6) months of the conclusion of the mentoring Dr Griffiths must provide a report demonstrating, to the satisfaction of the Board, that he has reflected on the issues that gave rise to the condition requiring he attend for mentoring and outlining how he has incorporated the lessons learnt in the mentoring into his practice.
3.9 All costs associated with compliance with the conditions on his registration are at Dr Griffiths' own expense.
4. The review period for the above conditions is twenty four (24) months from the date of Dr Griffiths' return to practice.
Note: The above determinations are imposed with the agreement of both parties.
SUPPRESSION ORDERS AND FILE ACCESS RESTRICTIONS IN FORCE**
Under s 146 of the Victorian Civil and Administrative Tribunal Act 1998 (Vic): no person other than a party to the proceeding or their legal representatives may inspect the Tribunal file.
Under s 17 of the Open Courts Act 2013 (Vic):
It was clear that there had in this case been 'a carefully and extensively negotiated outcome'.[2]
Evidence about the drugs prescribed and their actions
Tramadol is a synthetic opioid preparation used to treat moderate pain. It can create dependence and tolerance. It has in the past been suggested as an opioid substitute however it has of its own accord the potential for abuse and dependence.[3] It is contraindicated for use in opiate withdrawal. In patients who have a tendency for drug abuse or dependence it should be used for short periods. Cases of dependence and abuse of tramadol have been reported rarely.[4] There are no clinical studies measuring the safety of using tramadol beyond 6 months.[5]
Paracetamol 500mg/Codeine 30mg - Panadeine Forte, Codalgin Forte
Morphine (S8 schedule) is a potent drug derived from opium. It is used for severe pain in oral or injectable form. It can cause rapid dependence and withdrawal symptoms if ceased suddenly.
Paracetamol 500mg/codeine 30mg is a less potent opioid preparation however can but is less likely to cause dependence similarly to others in the class. Codeine is metabolised in the liver to morphine and norcodeine. It should be used with caution in patients with drug abuse or dependence.[7]
Fentanyl (S8 schedule) is a potent opioid analgesic. Used in a transdermal preparation it delivers a dose of the drug through the skin. It is indicated for the use of chronic pain when opioid analgesia has been considered necessary. The restricted benefit indicated is for 'chronic severe disabling pain not responding to non-narcotic analgesics.' It can be abused and dependency states can arise.[8]
Dr Michael McDonough, specialist in addiction medicine and toxicology at the Western Hospital states 'The evidence for harm associated with long-term opioid use is mounting while there is little evidence to support long term efficiency. In many cases, reducing and eventually stopping opioid therapy may be the best course of action.'[9] Dr McDonough also recommends the preparation of an opioid treatment plan and regular objective monitoring of function rather than relying on the patient's subjective analysis of their pain.[10]
MIMS 2014 advises in the treatment of non-malignant chronic pain:
'An initial comprehensive assessment should be conducted using a biopsychosocial approach to identify a cause for the pain, the appropriateness of opioid therapy, and to identify psychosocial factors that may exacerbate pain or magnify overall distress (e.g. depression, anxiety, post-traumatic stress disorder, borderline personality disorder, marked family stressors, history of sexual abuse). In the absence of a clear indication for a strong opioid analgesic, drug seeking behaviour must be suspected and resisted, particularly in individuals with a history of, or propensity for, drug abuse. Factors that may put the patient at increased risk of opioid abuse/addiction include a personal/family history of substance, prescription medication and alcohol abuse, and major psychosocial issues (e.g. psychological/psychiatric disorder). The use of opioids to treat predominant[ly] emotional distress should be avoided.
Generally, opioid analgesics are not initiated prior to a full initial clinical assessment and before consideration of other treatment options such as physiotherapy/exercise/rehabilitation approaches, psychosocial interventions such as CBT (cognitive behavioural therapy), self management approaches, involvement of a psychologist or psychiatrist to address psychological comorbidities which may be impacting on pain coping and trials of other non-opioid pharmacotherapeutic or interventional strategies.'
With respect to the use of Oxycontin, MIMS recommends:
Use of Oxycontin in 'chronic, non-malignant pain should be restricted to situations where all other conservative methods have been tried and have failed; the pain is having a significant impact on the patient's quality of life; there is no psychological contraindication, drug seeking behaviors or history of drug misuse... Should be integrated into a comprehensive approach...'[11]
There is an acknowledged non-medical use of opioids. For this reason, authors recommend universal precautions should be applied when prescribing these drugs rather than necessarily restricting prescribing policies. The precautions should include regular review, consideration of effectiveness, other non-opioid treatments, multidisciplinary referrals, close monitoring and restrictions on the amounts dispensed.[12] The Australian Medicines Handbook recommends that if an opioid such as oxycodone is used for chronic non-cancer pain, a specialist pain team should be involved.
The class of drugs known as benzodiazepines include diazepam, which has multiple trade names, but in relation to this matter specifically Valium. Adverse effects resulting from the use of benzodiazepines in general have been well documented over a number of years. They are known to be capable of abuse and physical dependence.[13] The phenomenon of tolerance and dependence is moderated by the drugs' effect on particular receptors in the brain.[14] A clinician prescribing any psychoactive medication needs to be mindful of the potential for misuse and set a clear endpoint to the use of the drug. Facilitation of a potentially serious problem can result from a clinician not denying drugs to persons with dependency problems.[15] Prescriptions for hypnotics should be limited to a few days and if used as anxiolytics should be in conjunction with other treatments such as counselling and anti-depressant medication. The length of time of use should be no longer than 2 - 4 weeks. Short courses at low doses may prevent the development of dependence.[16]
Alprazolam is a benzodiazepine, which has been associated with widespread illicit use. In particular alprazolam has been shown to be over represented in benzodiazepine events in Australia.[17] In cases of deliberate overdose by one form of benzodiazepine, alprazolam was found to be relatively more toxic than other benzodiazepines.[18] Its widespread use and misuse deserves special mention. Data collected by the Victorian Institute of Forensic Medicine at the time of the examination of individuals arrested by police for the year 2009 indicate the self-reporting of the use of alprazolam in 26% of persons arrested on suspicion of assault.
The Victorian Coroners Prevention Unit has collected data on deaths due to drugs and has found benzodiazepines feature in 50.3% of drug related deaths. This is exceeded only by opioid analgesics at 51.4%.[19]
An audit of overdose presentations was done in an inner Melbourne emergency department. It was found that alprazolam and diazepam were over-represented in the data relative to the rate of prescriptions in the population. In this study the most common source of the medication was prescription by the patients' usual doctor.[20]
RACGP Guidelines for the use of benzodiazepines
The guidelines are currently under review however the following applied to the period prior to 2014. These guidelines include as point 2) 'Dependence is neither a reason to continue prescribing nor a reason to refuse to prescribe. A short term response would be to prescribe a small quantity of benzodiazepine and seek specialist advice.'[21]
The RACGP's guide: Prescribing Drugs of Dependence will be released in the near future.
This is an antipsychotic medication indicated for the use in schizophrenia and bipolar disorder. In the last few years, reports have been emerging regarding the illicit use of Seroquel.
This is an antidepressant medication used for the treatment of major depression.
Aropax is an SSRI antidepressant Indicated for major depression, obsessive compulsive disorder, panic disorder, social anxiety, social phobia, generalised anxiety disorder, post traumatic stress disorder.
Aropax is associated with increased suicidality in children and adolescents with major depressive disorder. Long term safety data in children and adolescents concerning growth, maturation and cognitive and behavioural development are lacking.[22]
This is a sleeping medication. The indications are insomnia in adults. In general it is well tolerated but in recent years it has been associated with adverse effects including tolerance, dependence, psychiatric paradoxical reactions including hallucinations, nightmare, anger, abnormal behaviour, somnambulism and others.[23] The finding on 10 December 2014 by Coroner, Peter White into the death of Phoebe Handsjuk on 2 December 2010 included the statement '...there is a need for the Australian Therapeutic Goods Administration to review the conditions under which Stilnox is permitted to be prescribed and sold in Australia.'[24]
This is a SSRI anti-depressant medication. Indications for its use are major depression, social anxiety and generalised anxiety disorder.
This is a SNRI anti-depressant medication. It is indicated for major depression, generalised anxiety disorder, diabetic peripheral neuropathy pain, fibromyalgia and chronic musculoske[le]tal pain. It should not be used when there is liver disease also present.[25]
This is a SNRI antidepressant medication indicated for use in major depression and generalised anxiety.
Addiction has a physical basis and is an extremely prolonged illness, perhaps even life-long. The adaptation of the brain to the drug of addiction promotes the compulsive character of drug seeking in addicts.[26] In that drug abuse physically alters a neural pathway causing uncontrolled cravings; it should be viewed as a brain disease. Relapse following cessation can occur by a single drug dose.[27]
In context, this "insight" might be reflected in a variety of ways, such as an understanding of the nature of the conduct, an acceptance that the conduct was seriously wrong, an appreciation of why the practitioner engaged in that conduct, empathy with the consequences, and/or the willingness to take measures to identify risk factors and to avoid similar behaviour.
There is high authority for the proposition that the powers given to the disciplinary committee to discipline a practitioner are entirely protective in character. No element of punishment is involved... But to say that is merely to say that the powers are to be exercised for the purpose of, and in a manner seen likely to achieve, the maintenance of that high standard of conduct within the profession which will continue its good reputation, and protect, not only the future of the profession, but also protect its clients from harm.
With this object in mind, the committee is required to look to the future. Even if the practitioner's misconduct be relatively slight, he may yet be struck off, if his capacities and attitude have been revealed to be such that his continuance in practice constitutes a threat to the profession. On the other hand, conduct which is itself more grave in nature, may not warrant striking off, if it is seen as a temporary and explicable departure from the practitioner's own high standards... The order which the committee is called upon to make is that order which, in its opinion, is necessary, and no more than is necessary, to maintain professional discipline and high standards of conduct.
We have not attempted a detailed analysis of all the cases put before us by Mr Grace because, notwithstanding this Tribunal's desire to strive for consistency of decision-making, there is no such thing as a tariff in these disciplinary matters and each hearing turns on its own particular facts.
The relevance of the joint proposed determinations
Ultimately the question of the appropriate penalty in a particular case is a matter for the Tribunal, though the consent of the parties is clearly a significant consideration.[37]
Whenever possible, avoid providing medical care to anyone with whom you have a close personal relationship. In most cases, providing care to close friends, those you work with and family members is inappropriate because of the lack of objectivity, possible discontinuity of care, and risks to the doctor and patient. In some cases, providing care to those close to you is unavoidable. Whenever this is the case, good medical practice requires recognition and careful management of these issues.
it is generally agreed that combining a therapeutic and personal relationship may be detrimental to the welfare of the patient.
Dr Julian Walter summarises the legislative requirements for self and family prescribing in Australia by saying 'prescribing for family members should be avoided as a matter of good medical practice.'[39]
American research has found that when family members become ill, physicians confront competing expectations especially when circumstances arise that are seen by the doctor to prevent adequate care for the particular family member. The authors also point out that physicians will always be family members and the value of their emotional attachments to relatives should not be dismissed.'[40]
The major difference between a suspension and cancellation is that once the doctor's registration is cancelled, he must reapply after the period specified. It is not guaranteed that he will be so re-registered. He must satisfy the Board that registration is appropriate and that he fulfils the qualifications for general registration...
Cancellation of registration sends a clear message of unsuitability to practice. Suspension may be thought to indicate confidence in the doctor's future ability to practise once the period of suspension is served.
There are some cases in which it is abundantly clear that deregistration is the only option available to protect the public from a miscreant doctor.
This is apparent in situations in which the practitioner does not accept the inappropriateness of his conduct or has been shown to be a serial offender.
[1] Because there have been three Acts of Parliament regulating the conduct of medical practitioners over the period, separate allegations have to be made under each.
[2] Medical Board of Australia v Fox (Review and Regulation) [2016] VCAT 408.
[3] Duke A, Bigelow G, Lanier R, Strain E. Discriminative stimulus effects of tramadol in humans. J Pharmacol Exp Ther 2011 338(1) 255.
[9] McDonough M. Safe prescribing of opioids for persistent non-cancer pain. Australian Prescriber 2012 35(1).
[10] McDonough M. Safe prescribing of opioids for persistent non-cancer pain. Australian Prescriber 2012 35(1).
[12] Degenhardt L, Gilmour S, Shand F: Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia. Drug and Alcohol Review 2013 (32) 468-474.
[13] Busto U, Sellers EM. Pharmacologic aspects of benzodiazepine tolerance and dependence. J Subst Abuse treat 1991 8(1-2) 29.
[14] Leonard, B. Commentary on the mode of action of benzodiazepines; J Psychiatr Res. 1993 27(1) 193.
[15] Finch J. Prescription drug abuse; Primary Care 1993 20(1) 231.
[16] Ashton H, Guidelines for the rational use of benzodiazepines. When and what to use. Drugs 1994 48(1) 25.
[17] Moylan S, Giorlando F, Nordfjaern T, Berk M 'The role of alprazolam for the treatment of panic disorder in Australia' Australian and New Zealand Journal of Psychiatry (2012) 46(3) 212-224.
[18] Isbister G, O'Regan L, Sibbritt D, Whyte I 'Alprazolam is relatively more toxic than other benzodiazepines in overdose' British Journal of Clinical Pharmacology 2004 58(1) 88-95.
[19] Jeremy Dwyer 'Coronial Insights into understanding and preventing drug-related harms' Pharmaceutical Society of Australia, Harm Minimisation Forum, 12 September 2012.
[20] Buykx P, Loxley W, Dietze P, Ritter A 'Medications used in overdose and how they are acquired - an investigation of cases attending an inner Melbourne emergency department' Australia and New Zealand Journal of Public Health 2010 34(4) 401.
[21] The Royal Australian College of general Practitioners. Guidelines: benzodiazepines.
[24] Inquest into the death of Phoebe Handsjuk 2014.
[25] Eli Lilley prescribing information 2014.
[26] Kalivas P, Volkow N. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005 162(8) 1403.
[27] Clay S, Allen J, Parran T. A review of addiction. Postgrad Med 2008 120(2).
[28] See for example Medical Board of Australia v Jansz [2011] VCAT 1026, Medical Board of Australia v Fox [2016] VCAT 408 and Medical Board of Australia v Dr John Myers (Review and Regulation) [2013] VCAT 1315 [MPA and HPRA].
[29] Ha v Pharmacy Board of Victoria [2002] VSC 322 at paragraph [91] and [97] followed in Medical Practitioners Board of Victoria v Grolaux (No. 2) (Occupational and Business Regulation) [2009] VCAT 978; Health Care Complaints Commission v Lichfield [1997] NSWSC 297; (1997) 41 NSWLR 630 at 637; Medical Board of Australia v Janz [2011] VCAT 1026. Psychology Board of Australia v Mair [2010] VSC 628; Morris v Psychologists Registration Board (Unrep) Supreme Court of Victoria, 19 November 1997, per Harper J at 12.
[30] The risk of repetition of misconduct is an important factor for the Tribunal to consider: Ha v Pharmacy Board of Victoria at [101].
[31] [2009] VCAT 978 at [8].
[32] Per Ross J, in Brott v Legal Services Commissioner [2008] VCAT 2399 at [67]
[33] Unreported, Supreme Court of Tasmania. See also Chiropractic Board of Australia v Hooper [2013] VCAT 1346 at [22].
[34] Medical Board of Victoria v Myers [VCAT] 2013 1806 [17]-[18].
[35] Dental Practice Board of Victoria v Dr Hassed [2006] VSC 485 per Hargrave J.
[36] In Legal Services Commissioner v Zervas [2015] VCAT 356, Senior Member Smithers observed that it appeared that the approach taken by Ross J remained 'good law'.[25]
[38] Good Medical Practice: A Code of Conduct for Doctors in Australia (the Code).
[39] Dr Julian Walter, 'Prescribing for Self and Family' defence update September 18 2012.
[40] Frederick Chen, Chris Feudtner, Lorna Rhodes, 'Original Research: Role conflicts in physicians and their family members: rules but no rulebook', Western Journal of Medicine 2001: 175: 236-239.
Medical Board of Australia
Griffiths
(1997) 41 NSWLR 630